Business Context and Reporting Period
This Form 8-K Current Report was filed by SANUWAVE Health, Inc. on May 26, 2025. The filing reports a change in the composition of the Board of Directors, specifically the resignation of a director and the appointment of a replacement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Director Resignation: A. Michael Stolarski resigned from the Board of Directors, effective May 27, 2025. The resignation is not due to any disagreement with the Company or its management.
- Director Appointment: Gregory Bazar was appointed to the Board effective May 27, 2025, to serve until the 2025 annual meeting of stockholders or until a successor is elected.
- Committee Assignment: Mr. Bazar was appointed to the Compensation Committee.
Compensation and Outlook
In connection with his appointment, Mr. Bazar received the following compensatory arrangements:
- Initial Grant: 41,333 stock options at an exercise price of $27.97 per share. These options have a ten-year term and vest in 12 equal quarterly installments.
- Quarterly Grants: Fully vested stock options with a value of $20,000 (calculated using Black-Scholes valuation on the grant date) per quarter.
The filing states that Mr. Bazar has no interest in any related person transactions. No guidance, outlook, or risk factors regarding the Company's operations were disclosed in this specific filing.
Investor Verification Checklist
- Verify the effective date of the Board composition change (May 27, 2025).
- Confirm the vesting schedule and exercise price of the 41,333 options granted to the new director.
- Review the Company's upcoming 2025 annual meeting of stockholders to determine if Mr. Bazar will stand for election.
- Check for any subsequent filings regarding the resignation of Mr. Stolarski or the appointment of Mr. Bazar.